• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

2 Stocks You Definitely Should Consider Shorting This Week

These 'Bearish Bets' are showing both technical and quantitative deterioration.
By BOB LANG
May 14, 2019 | 11:30 AM EDT
Stocks quotes in this article: SFIX, BMRN

Using recent actions and grades from TheStreet's Quant Ratings and layering on technical analysis of the charts of those stocks, Trifecta Stocks identifies five names each Friday that look bearish.

While we will not be weighing in with fundamental analysis we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names.

Stitch Fix

Stitch Fix, Inc.  (SFIX)  recently was downgraded to Sell with a D+ rating by TheStreet's Quant Ratings.

Stitch Fix is a newer name that has been rattled. The stock of the online apparel retailer fell sharply in December but rallied strong, which included some powerful earnings. However, we see a massive shooting star and a bearish head-and-shoulders pattern, ominous and looking for more downside.

Relative strength is breaking down, and with a close below the lower Bollinger band this stock is headed down to Chinatown. This is a good short to the high teens.

BioMarin Pharmaceutical

BioMarin Pharmaceutical, Inc.  (BMRN)  recently was downgraded to Sell with a D+ rating by TheStreet's Quant Ratings.

Biotechs have been challenged for most of 2019, with some heading toward their December lows. Count BioMarin as one of them.

The stock chart looks abysmal, especially after breaking the range below the $87 level. Higher volume recently on the sell days is a good clue that big money is exiting the name. Moving average convergence divergence (MACD) is on a sell signal, too.

We could see that December low around $79 broken very soon; it's a short, and add more with a rally up.

This commentary is an excerpt from "5 Bearish Bets" a weekly feature sent to subscribers of Trifecta Stocks. Click here to learn more about this portfolio, trading ideas and market commentary product.

Want to find out the three other stocks we think look good short this week and how to play them? Click here for a trial subscription to Trifecta Stocks and get "Bearish Bets" each week!

-- Bob Lang and Chris Versace are co-portfolio managers of Trifecta Stocks.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Lang and Trifecta Stocks had no positions in the securities mentioned.

TAGS: Short-selling | Investing | Stocks | Technical Analysis | Trading | Quant Ratings | Trifecta Stocks | U.S. Equity

More from Stocks

We Are Cutting Our Market Outlook

Guy Ortmann
Mar 3, 2021 10:29 AM EST

Fewer stocks are participating in bounces from the recent increases in volatility.

Hits and Misses From the Early Days of What Would Become the Pandemic

Jonathan Heller
Mar 3, 2021 10:00 AM EST

Booking a cruise a year ago wasn't a great idea, but buying a discounted small-cap fund was; so was buying physical silver.

Canopy Growth Has Corrected but Needs More Accumulation

Bruce Kamich
Mar 3, 2021 9:46 AM EST

Let's review the charts and indicators.

XL Fleet's Charts Show Potential for a Future Purchase

Bruce Kamich
Mar 3, 2021 8:49 AM EST

A new base pattern needs to develop before taking a long position.

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Bret Jensen
Mar 3, 2021 8:30 AM EST

Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:50 AM EST PAUL PRICE

    Michaels: Close to a Deal?

    It appears that a deal could be announced soon. ...
  • 08:34 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 3/3/2021

    SPX (Long-Term View) The 20 DMA @ 3889 with the ...
  • 06:05 PM EST PAUL PRICE

    Michael's (MIK) Up on Takeover Rumors

    The NYT says talks are underway regarding a buyout...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login